Overview

Study of Letrozole in Recurrent Gliomas

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in gliomas.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Letrozole
Criteria
Inclusion Criteria:

- Recurrent brain glioma with plan for resection or biopsy.

- ECOG 0-2

- Adequate labs

Exclusion Criteria:

- Receiving other investigational agents.